AbbVie Inc recalls Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syring
Recalled May 7, 2014 · FDA recall D-1287-2014 · AbbVie
Hazard
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device. · FDA Class II
Units
7362 kits
Sold at
Nationwide and Puerto Rico
Description
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Product
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.
Manufacturer(s)
AbbVie Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →